Skip to main content
Medapp Spolka Akcyjna logo

Medapp Spolka Akcyjna — Investor Relations & Filings

Ticker · MDA ISIN · PLYLWHT00012 LEI · 259400325KF6BPQ17643 WAR Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 266 across all filing types
Latest filing 2024-03-27 Major Shareholding Noti…
Country PL Poland
Listing WAR MDA

About Medapp Spolka Akcyjna

http://www.medapp.pl

Medapp Spolka Akcyjna is a technology company that develops software solutions for digital medicine and advanced diagnostic imaging. The company's core focus is on creating tools that support medical professionals in diagnostics, treatment planning, and conducting complex medical procedures. Its flagship product, CarnaLife Holo, is an FDA-certified technology that provides three-dimensional visualization of medical imaging data using mixed and augmented reality. This system is utilized in fields such as cardiology and oncology to enhance procedural accuracy and planning. Other key offerings include the CarnaLife System, a telemedical platform for remote patient monitoring and data analysis, and HoloComm, a tool for remote 3D demonstrations. The company's solutions are built upon a foundation of artificial intelligence, 3D imaging, and big data analytics, developed through collaboration between engineers, software developers, and medical experts.

Recent filings

Filing Released Lang Actions
zal01_zawiadomienie_-_Amida_Capital.pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 ustawy o ofercie (wypełnia akcjonariusz)" which translates to "Notification pursuant to Art. 69 sec. 1 or 2 of the Public Offering Act (completed by the shareholder)". This structure strongly indicates a mandatory regulatory filing in Poland concerning changes in significant shareholdings. The content details the 'Stan posiadania podmiotu przed zmianą' (Shareholding status before change) and the resulting change, specifically noting a 'Sprzedaż - umowa cywilnoprawna' (Sale - civil law agreement) event. This directly corresponds to the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema, despite the Polish context, as it deals with changes in significant ownership thresholds.
2024-03-27 Polish
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmniejszenie stanu posiadania - Content (PL)
Major Shareholding Notification Classification · 1% confidence The document text is very short (292 characters) and states that the Management Board received a notification regarding a decrease in the shareholding percentage below the 5% threshold by 'Amida Capital sp. z o.o. SKA'. It explicitly mentions 'Treść zawiadomienia w załączeniu' (Content of the notification attached). This structure—a brief announcement referencing an attached document detailing a change in significant share ownership—strongly suggests a notification of a change in major shareholding. This aligns best with the Major Shareholding Notification (MRQ) definition, which covers changes in significant share ownership levels crossing thresholds. Given the brevity and the reference to an attachment, it is a notification about the event, not the full underlying report, but MRQ is the most specific category for the content described.
2024-03-27 Polish
Złożenie wniosku o udzielenie patentu w spółce Medapp Radiotherapy Sp. z o.o. - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement from the Management Board ('Zarząd') of Medapp S.A. regarding its subsidiary filing a patent application ('wniosek o udzielenie patentu') with the European Patent Office for a technology related to radiotherapy positioning using augmented reality. This concerns intellectual property development and protection, which is a form of corporate activity update. It is not a standard financial report (10-K, IR, ER), a management change (MANG), or a director's trade (DIRS). Since the document details a specific corporate action related to intellectual property and future business strategy, it fits best under 'Intellectual Property' (IP) or potentially 'Regulatory Filings' (RNS) if IP wasn't an option. Given the specific nature of patent filing, 'IP' is the most precise fit among the provided definitions, as it relates directly to the protection of the company's core technology.
2023-12-28 Polish
Podpisanie umowy o dofinansowanie z NCBiR - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement from the Management Board ('Zarząd spółki') of MedApp S.A. regarding the receipt of a signed funding agreement ('umowę o dofinansowanie projektu') from the National Centre for Research and Development (NCBR) for a project under the Eurostars-3 program. It details the project's purpose (monitoring chronic kidney disease), the consortium partners, the total cost (PLN 2,858,162.17), the amount of funding granted (PLN 2,286,529.74), and the project timeline (Nov 1, 2023, to April 30, 2026). This announcement concerns a significant financing activity and grant award, which directly relates to the company's capital structure and funding strategy. Therefore, it best fits the 'Capital/Financing Update' category (CAP). It is not a full financial report (10-K, IR), an earnings release (ER), or a general regulatory filing (RNS), as it pertains to a specific financing event.
2023-12-12 Polish
Podwyższenie kapitału zakładowego w spółce zależnej MedApp Clinical Research Sp. z o.o. - Content (PL)
Capital/Financing Update Classification · 1% confidence The document text, written in Polish, announces a change in the share capital (kapitał zakładowy) of a subsidiary, MedApp Clinical Research Sp. z o.o., increasing it significantly via a contribution in kind (aportem). This action directly relates to the capital structure and financing of the group. Based on the definitions, this falls under 'Capital/Financing Update' (CAP), as it details a substantial increase in the subsidiary's capital.
2023-12-06 Polish
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym Walnym Zgromadzeniu Spółki w dniu 25 września 2023 roku - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is very short (389 characters) and explicitly lists the major shareholders (those holding at least 5% of the votes) present at an Extraordinary General Meeting ('Nadzwyczajnym Walnym Zgromadzeniu Spółki' or EGM) held on April 3, 2023. This content directly relates to the results or proceedings of a shareholder vote/meeting, specifically detailing the voting power of large shareholders present. This aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it details who held voting rights and how many votes they commanded at that specific meeting.
2023-09-26 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.